Cell Source, Inc. — Form D
Cell Source, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-18. The offering totals $10.0M, of which $8.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-10-18
- Form: D
- Accession: 0001569340-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $8.9M
- Remaining: $1.1M
- Minimum investment: $25K
- Investors: 62
- Date of first sale: 2016-09-04
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-351394
Issuer
- Name: Cell Source, Inc.
- CIK: 0001569340
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2012
- Address: 57 WEST 57TH STREET, SUITE 400, NEW YORK, NY, 10019
- Phone: 616-416-7896
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Itamar Shimrat | Director | New York, NY |
| Yoram Drucker | Director | Technion City, Haifa, L3 |
| Yoram Drucker | Executive Officer | Technion City, Haifa, L3 |
| Dennis Brown | Director | New York, NY |
| George Verstraete | Director | New York, NY |
| Darlene Soave | Director | New York, NY |
| Itamar Shimrat | Executive Officer | New York, NY |
| Ben Friedman | Director | Tel Aviv, L3 |
| David Zolty | Director | TEL AVIV, L3 |
Other filings by this issuer (4)
More